Functional identification of activity‐regulated, high‐affinity glutamine transport in hippocampal neurons inhibited by riluzole
Glutamine (Gln) is considered the preferred precursor for the neurotransmitter pool of glutamate (Glu), the major excitatory transmitter in the mammalian CNS. Here, an activity‐regulated, high‐affinity Gln transport system is described in developing and mature neuron‐enriched hippocampal cultures th...
Saved in:
Published in | Journal of neurochemistry Vol. 142; no. 1; pp. 29 - 40 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
England
Blackwell Publishing Ltd
01.07.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Glutamine (Gln) is considered the preferred precursor for the neurotransmitter pool of glutamate (Glu), the major excitatory transmitter in the mammalian CNS. Here, an activity‐regulated, high‐affinity Gln transport system is described in developing and mature neuron‐enriched hippocampal cultures that is potently inhibited by riluzole (IC50 1.3 ± 0.5 μM), an anti‐glutamatergic drug, and is blocked by low concentrations of 2‐(methylamino)isobutyrate (MeAIB), a system A transport inhibitor. K+‐stimulated MeAIB transport displays an affinity (Km) for MeAIB of 37 ± 1.2 μM, saturates at ~ 200 μM, is dependent on extracellular Ca2+, and is blocked by inhibition of voltage‐gated Ca2+ channels. Spontaneous MeAIB transport is also dependent on extracellullar Ca2+ and voltage‐gated calcium channels, but is also blocked by the Na+ channel blocker tetrodotoxin, by Glu receptor antagonists, and by GABA indicating its dependence on intact neural circuits driven by endogenous glutamatergic activity. The transport of MeAIB itself does not rely on Ca2+, but on Na+ ions, and is pH sensitive. Activity‐regulated, riluzole‐sensitive spontaneous and K+‐stimulated transport is minimal at 7–8 days in vitro, coordinately induced during the next 2 weeks and is maximally expressed by days in vitro > 20; the known period for maturation of the Glu/Gln cycle and regulated pre‐synaptic Glu release. Competition analyses with various amino acids indicate that Gln is the most likely physiological substrate. Activity‐regulated Gln/MeAIB transport is not observed in astrocytes. The functional identification of activity‐regulated, high‐affinity, riluzole‐sensitive Gln/MeAIB transport in hippocampal neurons may have important ramifications in the neurobiology of activity‐stimulated pre‐synaptic Glu release, the Glu/Gln cycle between astrocytes and neurons, and neuronal Glu‐induced excitotoxicity.
Cover Image for this issue: doi: 10.1111/jnc.13805.
This report describes a Ca2+‐regulated ‘system A’ glutamine transport system in hippocampal neuron‐enriched primary cultures that is dependent on neural activity in mature synapses, potently inhibited by riluzole (a blocker of synaptic glutamate release), and that is up‐regulated during the critical postnatal period of functional maturation of the glutamate/glutamine cycle between astrocytes and neurons and synaptic glutamate release. The novel high‐affinity system A transporter described here may have physiological and pathological implications in understanding the neurobiology of excitotoxic synaptic glutamate release in acute and chronic neurodegenerative diseases.
Cover Image for this issue: doi: 10.1111/jnc.13805. |
---|---|
AbstractList | Abstract
Glutamine (Gln) is considered the preferred precursor for the neurotransmitter pool of glutamate (Glu), the major excitatory transmitter in the mammalian
CNS
. Here, an activity‐regulated, high‐affinity Gln transport system is described in developing and mature neuron‐enriched hippocampal cultures that is potently inhibited by riluzole (
IC
50
1.3 ± 0.5 μM), an anti‐glutamatergic drug, and is blocked by low concentrations of 2‐(methylamino)isobutyrate (Me
AIB
), a system A transport inhibitor. K
+
‐stimulated Me
AIB
transport displays an affinity (
K
m
) for Me
AIB
of 37 ± 1.2 μM, saturates at ~ 200 μM, is dependent on extracellular Ca
2+
, and is blocked by inhibition of voltage‐gated Ca
2+
channels. Spontaneous Me
AIB
transport is also dependent on extracellullar Ca
2+
and voltage‐gated calcium channels, but is also blocked by the Na
+
channel blocker tetrodotoxin, by Glu receptor antagonists, and by
GABA
indicating its dependence on intact neural circuits driven by endogenous glutamatergic activity. The transport of Me
AIB
itself does not rely on Ca
2+
, but on Na
+
ions, and is
pH
sensitive. Activity‐regulated, riluzole‐sensitive spontaneous and K
+
‐stimulated transport is minimal at 7–8 days
in vitro
, coordinately induced during the next 2 weeks and is maximally expressed by days
in vitro
> 20; the known period for maturation of the Glu/Gln cycle and regulated pre‐synaptic Glu release. Competition analyses with various amino acids indicate that Gln is the most likely physiological substrate. Activity‐regulated Gln/Me
AIB
transport is not observed in astrocytes. The functional identification of activity‐regulated, high‐affinity, riluzole‐sensitive Gln/Me
AIB
transport in hippocampal neurons may have important ramifications in the neurobiology of activity‐stimulated pre‐synaptic Glu release, the Glu/Gln cycle between astrocytes and neurons, and neuronal Glu‐induced excitotoxicity.
image
Cover Image
for this issue: doi:
10.1111/jnc.13805
. Glutamine (Gln) is considered the preferred precursor for the neurotransmitter pool of glutamate (Glu), the major excitatory transmitter in the mammalian CNS. Here, an activity-regulated, high-affinity Gln transport system is described in developing and mature neuron-enriched hippocampal cultures that is potently inhibited by riluzole (IC50 1.3 ± 0.5 μM), an anti-glutamatergic drug, and is blocked by low concentrations of 2-(methylamino)isobutyrate (MeAIB), a system A transport inhibitor. K+ -stimulated MeAIB transport displays an affinity (Km ) for MeAIB of 37 ± 1.2 μM, saturates at ~ 200 μM, is dependent on extracellular Ca2+ , and is blocked by inhibition of voltage-gated Ca2+ channels. Spontaneous MeAIB transport is also dependent on extracellullar Ca2+ and voltage-gated calcium channels, but is also blocked by the Na+ channel blocker tetrodotoxin, by Glu receptor antagonists, and by GABA indicating its dependence on intact neural circuits driven by endogenous glutamatergic activity. The transport of MeAIB itself does not rely on Ca2+ , but on Na+ ions, and is pH sensitive. Activity-regulated, riluzole-sensitive spontaneous and K+ -stimulated transport is minimal at 7-8 days in vitro, coordinately induced during the next 2 weeks and is maximally expressed by days in vitro > 20; the known period for maturation of the Glu/Gln cycle and regulated pre-synaptic Glu release. Competition analyses with various amino acids indicate that Gln is the most likely physiological substrate. Activity-regulated Gln/MeAIB transport is not observed in astrocytes. The functional identification of activity-regulated, high-affinity, riluzole-sensitive Gln/MeAIB transport in hippocampal neurons may have important ramifications in the neurobiology of activity-stimulated pre-synaptic Glu release, the Glu/Gln cycle between astrocytes and neurons, and neuronal Glu-induced excitotoxicity. Cover Image for this issue: doi: 10.1111/jnc.13805. Glutamine (Gln) is considered the preferred precursor for the neurotransmitter pool of glutamate (Glu), the major excitatory transmitter in the mammalian CNS. Here, an activity-regulated, high-affinity Gln transport system is described in developing and mature neuron-enriched hippocampal cultures that is potently inhibited by riluzole (IC 1.3 ± 0.5 μM), an anti-glutamatergic drug, and is blocked by low concentrations of 2-(methylamino)isobutyrate (MeAIB), a system A transport inhibitor. K -stimulated MeAIB transport displays an affinity (K ) for MeAIB of 37 ± 1.2 μM, saturates at ~ 200 μM, is dependent on extracellular Ca , and is blocked by inhibition of voltage-gated Ca channels. Spontaneous MeAIB transport is also dependent on extracellullar Ca and voltage-gated calcium channels, but is also blocked by the Na channel blocker tetrodotoxin, by Glu receptor antagonists, and by GABA indicating its dependence on intact neural circuits driven by endogenous glutamatergic activity. The transport of MeAIB itself does not rely on Ca , but on Na ions, and is pH sensitive. Activity-regulated, riluzole-sensitive spontaneous and K -stimulated transport is minimal at 7-8 days in vitro, coordinately induced during the next 2 weeks and is maximally expressed by days in vitro > 20; the known period for maturation of the Glu/Gln cycle and regulated pre-synaptic Glu release. Competition analyses with various amino acids indicate that Gln is the most likely physiological substrate. Activity-regulated Gln/MeAIB transport is not observed in astrocytes. The functional identification of activity-regulated, high-affinity, riluzole-sensitive Gln/MeAIB transport in hippocampal neurons may have important ramifications in the neurobiology of activity-stimulated pre-synaptic Glu release, the Glu/Gln cycle between astrocytes and neurons, and neuronal Glu-induced excitotoxicity. Cover Image for this issue: doi: 10.1111/jnc.13805. Glutamine (Gln) is considered the preferred precursor for the neurotransmitter pool of glutamate (Glu), the major excitatory transmitter in the mammalian CNS. Here, an activity-regulated, high-affinity Gln transport system is described in developing and mature neuron-enriched hippocampal cultures that is potently inhibited by riluzole (IC 50 1.3 +/− 0.5µM), an anti-glutamatergic drug, and is blocked by low concentrations of 2-(methylamino)isobutyrate (MeAIB), a system A transport inhibitor. K + -stimulated MeAIB transport displays an affinity ( K m ) for MeAIB of 37 +/− 1.2 µM, saturates at ~200 µM, is dependent on extracellular Ca 2+ , and is blocked by inhibition of voltage gated Ca 2+ -channels (VGCCs). Spontaneous MeAIB transport is also dependent on extracellullar Ca 2+ and VGCCs, but is also blocked by the Na + channel blocker tetrodotoxin, by Glu receptor antagonists, and by GABA indicating its dependence on intact neural circuits driven by endogenous glutamatergic activity. The transport of MeAIB itself does not rely on Ca 2+ , but on Na + ions, and is pH-sensitive. Activity-regulated, riluzole-sensitive spontaneous and K + -stimulated transport is minimal at 7–8 days in vitro (DIV), coordinantly induced during the next two weeks, and is maximally expressed by DIV>20; the known period for maturation of the Glu/Gln cycle and regulated presynaptic Glu release. Competition analyses with various amino acids indicate that Gln is the most likely physiological substrate. Activity-regulated Gln/MeAIB transport is not observed in astrocytes. The functional identification of activity-regulated, high-affinity, riluzole-sensitive Gln/MeAIB transport in hippocampal neurons may have important ramifications in the neurobiology of activity stimulated presynaptic Glu release, the Glu/Gln cycle between astrocytes and neurons, and neuronal Glu-induced excitotoxicity. This report describes a Ca 2+ -regulated ‘system A’ glutamine transport system in hippocampal neuron-enriched primary cultures that is dependent on neural activity in mature synapses, potently inhibited by riluzole (a blocker of synaptic glutamate release), and that is up-regulated during the critical postnatal period of functional maturation of the glutamate/glutamine cycle between astrocytes and neurons and synaptic glutamate release. The novel high-affinity system A transporter described here may have physiological and pathological implications in understanding the neurobiology of excitotoxic synaptic glutamate release in acute and chronic neurodegenerative diseases. Glutamine (Gln) is considered the preferred precursor for the neurotransmitter pool of glutamate (Glu), the major excitatory transmitter in the mammalian CNS. Here, an activity‐regulated, high‐affinity Gln transport system is described in developing and mature neuron‐enriched hippocampal cultures that is potently inhibited by riluzole (IC50 1.3 ± 0.5 μM), an anti‐glutamatergic drug, and is blocked by low concentrations of 2‐(methylamino)isobutyrate (MeAIB), a system A transport inhibitor. K+‐stimulated MeAIB transport displays an affinity (Km) for MeAIB of 37 ± 1.2 μM, saturates at ~ 200 μM, is dependent on extracellular Ca2+, and is blocked by inhibition of voltage‐gated Ca2+ channels. Spontaneous MeAIB transport is also dependent on extracellullar Ca2+ and voltage‐gated calcium channels, but is also blocked by the Na+ channel blocker tetrodotoxin, by Glu receptor antagonists, and by GABA indicating its dependence on intact neural circuits driven by endogenous glutamatergic activity. The transport of MeAIB itself does not rely on Ca2+, but on Na+ ions, and is pH sensitive. Activity‐regulated, riluzole‐sensitive spontaneous and K+‐stimulated transport is minimal at 7–8 days in vitro, coordinately induced during the next 2 weeks and is maximally expressed by days in vitro > 20; the known period for maturation of the Glu/Gln cycle and regulated pre‐synaptic Glu release. Competition analyses with various amino acids indicate that Gln is the most likely physiological substrate. Activity‐regulated Gln/MeAIB transport is not observed in astrocytes. The functional identification of activity‐regulated, high‐affinity, riluzole‐sensitive Gln/MeAIB transport in hippocampal neurons may have important ramifications in the neurobiology of activity‐stimulated pre‐synaptic Glu release, the Glu/Gln cycle between astrocytes and neurons, and neuronal Glu‐induced excitotoxicity. Cover Image for this issue: doi: 10.1111/jnc.13805. This report describes a Ca2+‐regulated ‘system A’ glutamine transport system in hippocampal neuron‐enriched primary cultures that is dependent on neural activity in mature synapses, potently inhibited by riluzole (a blocker of synaptic glutamate release), and that is up‐regulated during the critical postnatal period of functional maturation of the glutamate/glutamine cycle between astrocytes and neurons and synaptic glutamate release. The novel high‐affinity system A transporter described here may have physiological and pathological implications in understanding the neurobiology of excitotoxic synaptic glutamate release in acute and chronic neurodegenerative diseases. Cover Image for this issue: doi: 10.1111/jnc.13805. Glutamine (Gln) is considered the preferred precursor for the neurotransmitter pool of glutamate (Glu), the major excitatory transmitter in the mammalian CNS. Here, an activity-regulated, high-affinity Gln transport system is described in developing and mature neuron-enriched hippocampal cultures that is potently inhibited by riluzole (IC50 1.3 ± 0.5 µM), an anti-glutamatergic drug, and is blocked by low concentrations of 2-(methylamino)isobutyrate (MeAIB), a system A transport inhibitor. K+-stimulated MeAIB transport displays an affinity (Km) for MeAIB of 37 ± 1.2 µM, saturates at ~ 200 µM, is dependent on extracellular Ca2+, and is blocked by inhibition of voltage-gated Ca2+ channels. Spontaneous MeAIB transport is also dependent on extracellullar Ca2+ and voltage-gated calcium channels, but is also blocked by the Na+ channel blocker tetrodotoxin, by Glu receptor antagonists, and by GABA indicating its dependence on intact neural circuits driven by endogenous glutamatergic activity. The transport of MeAIB itself does not rely on Ca2+, but on Na+ ions, and is pH sensitive. Activity-regulated, riluzole-sensitive spontaneous and K+-stimulated transport is minimal at 7-8 days in vitro, coordinately induced during the next 2 weeks and is maximally expressed by days in vitro > 20; the known period for maturation of the Glu/Gln cycle and regulated pre-synaptic Glu release. Competition analyses with various amino acids indicate that Gln is the most likely physiological substrate. Activity-regulated Gln/MeAIB transport is not observed in astrocytes. The functional identification of activity-regulated, high-affinity, riluzole-sensitive Gln/MeAIB transport in hippocampal neurons may have important ramifications in the neurobiology of activity-stimulated pre-synaptic Glu release, the Glu/Gln cycle between astrocytes and neurons, and neuronal Glu-induced excitotoxicity. Cover Image for this issue: doi: 10.1111/jnc.13805. |
Author | Erickson, Jeffrey D. |
Author_xml | – sequence: 1 givenname: Jeffrey D. orcidid: 0000-0003-4598-9898 surname: Erickson fullname: Erickson, Jeffrey D. email: jerick@lsuhsc.edu organization: Lousiania State University Health New Orleans |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28423185$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kd1qFDEYhoNU7LZ64A3IgCcKTptkkmzmRJDF-kPREz0O32SS3SyZZExmKtujgjfgNXolZt1aVDAnge99ePiS9wQdhRgMQo8JPiPlnG-DPiMMM3EPLQhbkpoR3h6hBcaU1g1m9Bid5LzFmAgmyAN0TCWjDZF8gb5dzEFPLgbwletNmJx1GvaDKtoKSnTlpt2Pm-_JrGcPk-lfVBu33pQJWOtCCau1nycYXDDVlCDkMaapcqFg4xg1DGNRBzOnGHIZb1zniqXqdlVyfr6O3jxE9y34bB7d3qfo88XrT6u39eXHN-9Wry5rzVgjass73WC55KbhjWS2lxK3sgPdMaopBbOkwBlwaQohlkIKLTvDuejBgjXQnKKXB-84d4PpdXltAq_G5AZIOxXBqb-T4DZqHa8U5y3jQhbBs1tBil9mkyc1uKyN9xBMnLMisiVYtpLu0af_oNs4p_LLhWoJ4UTIlhbq-YHSKeacjL1bhmC1r1aVatWvagv75M_t78jfXRbg_AB8dd7s_m9S7z-sDsqfseW15Q |
CitedBy_id | crossref_primary_10_1016_j_aquaculture_2020_735257 crossref_primary_10_1016_j_neuint_2018_12_006 crossref_primary_10_1016_j_neuropharm_2021_108719 crossref_primary_10_3390_ijms22031167 crossref_primary_10_1007_s12035_024_03966_3 crossref_primary_10_1016_j_neuropharm_2022_109349 crossref_primary_10_1152_ajplung_00461_2020 crossref_primary_10_1007_s11064_020_02974_8 crossref_primary_10_1016_j_mce_2018_07_008 crossref_primary_10_1016_j_crphys_2023_100109 crossref_primary_10_3390_ijms24043841 crossref_primary_10_1007_s12035_020_01912_7 crossref_primary_10_1002_1873_3468_13584 crossref_primary_10_1016_j_ecoenv_2022_113783 crossref_primary_10_1111_jnc_15224 crossref_primary_10_1111_jnc_15238 crossref_primary_10_1007_s12035_018_1433_x crossref_primary_10_3390_ph15101297 |
Cites_doi | 10.1523/JNEUROSCI.1466-13.2013 10.1523/JNEUROSCI.20-04-01342.2000 10.1007/s00424-003-1117-9 10.1111/j.1460-9568.2010.07378.x 10.1016/j.ejmech.2016.11.053 10.1002/jnr.490350513 10.1074/jbc.M806407200 10.1038/nrn3379 10.1111/j.1460-9568.2007.05967.x 10.1074/jbc.M806470200 10.1016/S0079-6123(07)63041-6 10.1006/exnr.1997.6554 10.2741/2067 10.1089/neu.2015.4373 10.1101/lm.54603 10.1126/science.7569903 10.1074/jbc.M110.162404 10.1016/0006-8993(89)90045-0 10.1016/j.neuroscience.2004.01.019 10.1083/jcb.200201070 10.1016/j.brainres.2010.11.064 10.1007/978-3-319-45096-4_8 10.1007/s10072-011-0828-5 10.1016/0304-3940(92)90108-J 10.1212/WNL.59.9_suppl_5.S3 10.1016/S0896-6273(00)81203-9 10.1016/0014-2999(93)90037-I 10.1016/j.mam.2012.07.012 10.1523/JNEUROSCI.23-23-08212.2003 10.1111/j.1748-1716.2006.01552.x 10.1016/0306-4522(80)90130-X 10.1111/j.1471-4159.1984.tb05396.x 10.1016/0006-8993(79)90307-X 10.1023/A:1015255312948 10.1046/j.1471-4159.2003.01713.x 10.1016/j.neuron.2013.12.026 10.1038/mp.2016.33 10.1016/S0304-3940(99)00810-1 10.1016/0304-3940(92)90597-Z 10.1042/bj2990321 10.1179/016164107X159225 10.1016/S0304-3940(00)01536-6 10.1074/jbc.M608548200 10.1523/JNEUROSCI.1198-07.2007 10.1111/j.1527-3458.1997.tb00318.x 10.1177/088307389701200802 10.1152/physrev.1990.70.1.43 10.1212/WNL.47.6_Suppl_4.233S 10.1016/j.eplepsyres.2013.08.007 10.1016/j.neuroscience.2009.09.015 10.1097/00001756-200507130-00011 10.1523/JNEUROSCI.5221-04.2005 10.1007/BF00370302 10.1007/s13311-014-0305-y 10.1038/sj.jcbfm.9600490 10.1046/j.1471-4159.2001.00074.x 10.1523/JNEUROSCI.3003-04.2005 10.1523/JNEUROSCI.09-11-03720.1989 10.1093/cercor/bhn151 10.1523/JNEUROSCI.23-30-09697.2003 10.1073/pnas.121183498 10.1046/j.1460-9568.1999.00540.x 10.1046/j.1471-4159.2001.00156.x 10.1016/j.biopha.2016.12.067 10.1016/j.jmb.2014.10.016 10.1097/00001756-200207020-00019 10.1021/acsami.6b01776 10.1007/PL00005241 10.1074/jbc.M212718200 10.1002/jnr.23561 10.1074/jbc.M200374200 10.1016/j.neuroscience.2005.08.083 10.1016/j.neuron.2009.06.010 10.1016/S0301-0082(96)00049-4 10.1097/00001756-199806220-00037 10.1016/j.neuint.2005.11.016 10.1152/jn.00464.2004 10.1111/jnc.13230 10.1111/j.1471-4159.2012.07684.x 10.1074/jbc.M110942200 10.3389/fendo.2013.00059 10.1523/JNEUROSCI.0106-09.2010 10.1152/jn.00665.2001 10.1523/JNEUROSCI.23-05-01563.2003 |
ContentType | Journal Article |
Copyright | 2017 International Society for Neurochemistry 2017 International Society for Neurochemistry. Copyright © 2017 International Society for Neurochemistry |
Copyright_xml | – notice: 2017 International Society for Neurochemistry – notice: 2017 International Society for Neurochemistry. – notice: Copyright © 2017 International Society for Neurochemistry |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QR 7TK 7U7 7U9 8FD C1K FR3 H94 P64 7X8 5PM |
DOI | 10.1111/jnc.14046 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Chemoreception Abstracts Neurosciences Abstracts Toxicology Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Virology and AIDS Abstracts Technology Research Database Toxicology Abstracts AIDS and Cancer Research Abstracts Chemoreception Abstracts Engineering Research Database Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic MEDLINE Virology and AIDS Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Chemistry |
EISSN | 1471-4159 |
EndPage | 40 |
ExternalDocumentID | 10_1111_jnc_14046 28423185 JNC14046 |
Genre | article Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: LSUHSC Research Enhancement Fund funderid: 5497500049 – fundername: National Institute of Mental Health funderid: R21 14975051 – fundername: NIMH NIH HHS grantid: R21 MH101612 |
GroupedDBID | --- -~X .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 24P 29L 2WC 31~ 33P 36B 3SF 4.4 41~ 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAYJJ AAZKR ABCQN ABCUV ABEML ABIVO ABLJU ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFO ACGFS ACGOD ACGOF ACIWK ACMXC ACNCT ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFRAH AFZJQ AHBTC AHEFC AI. AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BAWUL BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DC6 DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 E3Z EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FIJ FUBAC FZ0 G-S G.N GAKWD GODZA GX1 H.X HF~ HGLYW HH5 HVGLF HZI HZ~ IH2 IHE IPNFZ IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MVM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI TWZ UB1 V8K VH1 W8V W99 WBKPD WIH WIJ WIK WIN WNSPC WOHZO WOW WQJ WRC WUP WXI WXSBR WYISQ X7M XG1 XJT YFH YNH YOC YUY ZGI ZXP ZZTAW ~IA ~KM ~WT CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QR 7TK 7U7 7U9 8FD C1K FR3 H94 P64 7X8 5PM |
ID | FETCH-LOGICAL-c4436-f5bc30875e35384fd88098bacb42c22ae72a54a58e5e367686c8be556dafafea3 |
IEDL.DBID | DR2 |
ISSN | 0022-3042 |
IngestDate | Tue Sep 17 21:16:32 EDT 2024 Thu Jul 25 09:33:18 EDT 2024 Thu Oct 10 22:13:02 EDT 2024 Fri Aug 23 02:03:41 EDT 2024 Tue Aug 27 13:44:50 EDT 2024 Sat Aug 24 00:55:58 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | neurotransmitter cycling neuronal glutamine transporter glutamate/glutamine cycle excitotoxicity activity-dependent regulation neuroprotection |
Language | English |
License | 2017 International Society for Neurochemistry. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4436-f5bc30875e35384fd88098bacb42c22ae72a54a58e5e367686c8be556dafafea3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 DR. JEFFREY D. ERICKSON (Orcid ID : 0000-0003-4598-9898) |
ORCID | 0000-0003-4598-9898 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.14046 |
PMID | 28423185 |
PQID | 1911516892 |
PQPubID | 31528 |
PageCount | 12 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5594568 proquest_miscellaneous_1891089828 proquest_journals_1911516892 crossref_primary_10_1111_jnc_14046 pubmed_primary_28423185 wiley_primary_10_1111_jnc_14046_JNC14046 |
PublicationCentury | 2000 |
PublicationDate | July 2017 |
PublicationDateYYYYMMDD | 2017-07-01 |
PublicationDate_xml | – month: 07 year: 2017 text: July 2017 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: New York |
PublicationTitle | Journal of neurochemistry |
PublicationTitleAlternate | J Neurochem |
PublicationYear | 2017 |
Publisher | Blackwell Publishing Ltd |
Publisher_xml | – name: Blackwell Publishing Ltd |
References | 1994; 299 2013; 29 2002; 59 2012; 121 2013; 4 2004; 125 2002; 157 2002; 13 2002; 277 2000; 294 2015; 427 1999; 288 1998; 358 2006; 137 2003; 278 1997; 3 2004; 447 2003; 10 2016; 34 2005; 25 1997; 147 1993; 35 1997; 51 2013; 14 2015; 135 2002; 88 1997; 12 2016; 87 1999; 11 1993; 250 2009; 284 2009; 164 2009; 19 2003; 85 2010; 30 2011; 286 2007; 26 2007; 27 2001; 98 2011; 1371 2015; 12 1979; 168 2010; 32 2009; 63 1992; 140 2007; 282 2015; 93 2000; 26 1984; 43 1992; 147 2007; 163 2013; 107 1989; 9 2000; 20 1994; 45 2002; 3 2016; 126 2007; 12 2012; 33 1991; 419 2016; 13 2014; 81 2004; 92 2013; 33 1997; 282 2013; 34 1989; 483 2006; 48 1980; 5 2006; 187 1995; 269 2016 1999; 276 1996; 47 2005; 16 2016; 8 1990; 70 1998; 9 2003; 23 2001; 76 2016; 22 e_1_2_8_28_1 e_1_2_8_26_1 e_1_2_8_49_1 e_1_2_8_68_1 Kanthasamy A. G. (e_1_2_8_47_1) 1999; 288 e_1_2_8_3_1 Herbert T. (e_1_2_8_37_1) 1994; 45 e_1_2_8_81_1 e_1_2_8_5_1 e_1_2_8_7_1 e_1_2_8_9_1 e_1_2_8_20_1 e_1_2_8_43_1 e_1_2_8_66_1 e_1_2_8_89_1 e_1_2_8_22_1 e_1_2_8_45_1 e_1_2_8_64_1 e_1_2_8_87_1 e_1_2_8_62_1 e_1_2_8_85_1 e_1_2_8_41_1 e_1_2_8_60_1 e_1_2_8_83_1 e_1_2_8_17_1 e_1_2_8_19_1 e_1_2_8_13_1 e_1_2_8_36_1 e_1_2_8_59_1 e_1_2_8_15_1 e_1_2_8_38_1 e_1_2_8_57_1 Gois S. (e_1_2_8_23_1) 2005; 25 e_1_2_8_70_1 e_1_2_8_32_1 e_1_2_8_55_1 e_1_2_8_78_1 e_1_2_8_11_1 e_1_2_8_34_1 e_1_2_8_53_1 e_1_2_8_76_1 e_1_2_8_51_1 e_1_2_8_74_1 e_1_2_8_30_1 e_1_2_8_72_1 e_1_2_8_25_1 e_1_2_8_46_1 e_1_2_8_27_1 e_1_2_8_48_1 e_1_2_8_69_1 e_1_2_8_2_1 e_1_2_8_80_1 e_1_2_8_4_1 e_1_2_8_6_1 e_1_2_8_8_1 e_1_2_8_21_1 Deken S. L. (e_1_2_8_24_1) 2003; 23 e_1_2_8_42_1 e_1_2_8_67_1 e_1_2_8_88_1 e_1_2_8_44_1 e_1_2_8_65_1 e_1_2_8_86_1 e_1_2_8_63_1 e_1_2_8_84_1 e_1_2_8_40_1 e_1_2_8_61_1 e_1_2_8_82_1 e_1_2_8_18_1 e_1_2_8_39_1 e_1_2_8_14_1 e_1_2_8_35_1 e_1_2_8_16_1 e_1_2_8_58_1 e_1_2_8_79_1 Song J. H. (e_1_2_8_77_1) 1997; 282 e_1_2_8_10_1 e_1_2_8_31_1 e_1_2_8_56_1 e_1_2_8_12_1 Erickson J. D. (e_1_2_8_29_1) 2016 e_1_2_8_33_1 e_1_2_8_54_1 e_1_2_8_75_1 e_1_2_8_52_1 e_1_2_8_73_1 e_1_2_8_50_1 e_1_2_8_71_1 |
References_xml | – volume: 26 start-page: 3437 year: 2007 end-page: 3448 article-title: Regulated recycling and plasma membrane recruitment of the high‐affinity choline transporter publication-title: Eur. J. Neurosci. – volume: 447 start-page: 784 year: 2004 end-page: 795 article-title: Sodium‐coupled neutral amino acid (System N/A) transporters of the SLC38 gene family publication-title: Pflugers Arch. – volume: 147 start-page: 209 year: 1992 end-page: 212 article-title: Riluzole inhibits the release of glutamate in the caudate nucleus of the cat publication-title: Neurosci. Lett. – volume: 13 start-page: 1167 year: 2002 end-page: 1170 article-title: Lamotrigine derivatives and riluzole inhibit INa2P in cortical neurons publication-title: NeuroReport – volume: 107 start-page: 20 year: 2013 end-page: 36 article-title: Electrographic seizures are significantly reduced by in vivo inhibition of neuronal uptake of extracellular glutamine in rat hippocampus publication-title: Epilepsy Res. – volume: 93 start-page: 1031 year: 2015 end-page: 1044 article-title: Maintaining the presynaptic glutamate supply for excitatory neurotransmission publication-title: J. Neurosci. Res. – volume: 3 start-page: 51 year: 2002 end-page: 56 article-title: Excited to death: different ways to lose your neurons publication-title: Biogerontology – volume: 88 start-page: 2302 year: 2002 end-page: 2310 article-title: Block of glutamate‐glutamine cycle between astrocytes and neurons inhibits epileptiform activity in hippocampus publication-title: J. Neurophysiol. – volume: 11 start-page: 1349 year: 1999 end-page: 1361 article-title: Unexpected localization of the Na /Cl dependent‐like orphan transporter, Rxt1, on synaptic vesicles in the rat central nervous system publication-title: Eur. J. Neurosci. – volume: 187 start-page: 273 year: 2006 end-page: 283 article-title: The role of the neutral amino acid transporter SNAT2 in cell volume regulation publication-title: Acta Physiol. (Oxf) – volume: 358 start-page: 181 year: 1998 end-page: 190 article-title: Riluzole, a glutamate release inhibitor, and motor behavior. publication-title: Arch. Pharm. – volume: 9 start-page: 2109 year: 1998 end-page: 2114 article-title: Excitotoxicity and repair of cochlear synapses after noise‐trauma induced hearing loss publication-title: NeuroReport – volume: 121 start-page: 184 year: 2012 end-page: 196 article-title: Synaptic vesicles are capable of synthesizing the VGLUT substrate glutamate from α‐ketoglutarate for vesicular loading publication-title: J. Neurochem. – volume: 25 start-page: 7121 year: 2005 end-page: 7133 article-title: Homeostatic scaling of vesicular glutamate and GABA transporter expression in rat neocortical circuits publication-title: J. Neurosci. – volume: 9 start-page: 3720 year: 1989 end-page: 3727 article-title: Riluzole, a novel antiglutamate, prevents memory loss and hippocampal neuronal damage in ischemic gerbils publication-title: J. Neurosci. – volume: 23 start-page: 9697 year: 2003 end-page: 9709 article-title: Vesicular localization and activity‐dependent trafficking of presynaptic choline transporters publication-title: J. Neurosci. – volume: 10 start-page: 86 year: 2003 end-page: 98 article-title: BDNF and activity‐dependent synaptic modulation publication-title: Learn. Mem. – volume: 483 start-page: 143 year: 1989 end-page: 148 article-title: Phenytoin protects against ischemia‐produced neuronal cell death publication-title: Brain Res. – volume: 59 start-page: S3 year: 2002 end-page: S6 article-title: Seizure‐induced neuronal injury: animal data publication-title: Neurology – volume: 33 start-page: 223 year: 2012 end-page: 237 article-title: The role of glutamate in neuronal ischemic injury: the role of spark in fire publication-title: Neurol. Sci. – volume: 137 start-page: 241 year: 2006 end-page: 251 article-title: Alpha‐linolenic acid and riluzole treatment confer cerebral protection and improve survival after focal brain ischemia publication-title: Neuroscience – volume: 43 start-page: 1369 year: 1984 end-page: 1374 article-title: Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis publication-title: J. Neurochem. – volume: 276 start-page: 127 year: 1999 end-page: 130 article-title: Effects of anticonvulsants on veratridine‐ and KCl‐evoked glutamate release from rat cortical synaptosomes publication-title: Neurosci. Lett. – volume: 299 start-page: 321 issue: Pt 2 year: 1994 end-page: 334 article-title: Regulatory and molecular aspects of mammalian amino acid transport publication-title: Biochem. J. – volume: 19 start-page: 1092 year: 2009 end-page: 1106 article-title: System A transporter SNAT2 mediates replenishment of dendritic pools controlling retrograde signaling by glutamate publication-title: Cereb. Cortex – volume: 92 start-page: 2714 year: 2004 end-page: 2724 article-title: Developmental changes in release properties of the CA3‐CA1 glutamate synapse in rat hippocampus publication-title: J. Neurophysiol. – volume: 126 start-page: 614 year: 2016 end-page: 630 article-title: Synthesis and biological evaluation of a new class of benzothiazines as neuroprotective agents publication-title: Eur. J. Med. Chem. – volume: 12 start-page: 234 year: 2015 end-page: 249 article-title: The riluzole derivative 2‐amino‐6‐trifluoromethylthio‐benzothiazole (SKA‐19), a mixed KCa2 activator and Na V blocker, is a potent novel anticonvulsant publication-title: Neurotherapeutics – volume: 81 start-page: 888 year: 2014 end-page: 900 article-title: A local glutamate‐glutamine cycle sustains synaptic excitatory transmitter release publication-title: Neuron – volume: 87 start-page: 135 year: 2016 end-page: 144 article-title: Riluzole ameliorates learning and memory deficits in Aβ25‐35‐induced rat model of Alzheimer's disease and is independent of cholinoceptor activation publication-title: Biomed. Pharmacother. – volume: 47 start-page: S233 issue: 6 Suppl 4 year: 1996 end-page: S241 article-title: The pharmacology and mechanism of action of riluzole publication-title: Neurology – volume: 35 start-page: 567 year: 1993 end-page: 576 article-title: Optimized survival of hippocampal neurons in B27‐supplemented Neurobasal, a new serum‐free medium combination publication-title: J. Neurosci. Res. – volume: 13 start-page: 223 year: 2016 end-page: 257 article-title: The glutamine transporters and their role in the glutamate/GABA‐glutamine cycle publication-title: Adv. Neurobiol. – volume: 30 start-page: 1288 year: 2010 end-page: 1300 article-title: Glutamine is required for persistent epileptiform activity in the disinhibited neocortical brain slice publication-title: J. Neurosci. – volume: 125 start-page: 191 year: 2004 end-page: 201 article-title: Mechanisms underlying the riluzole inhibition of glutamate release from rat cerebral cortex nerve terminals (synaptosomes) publication-title: Neuroscience – volume: 85 start-page: 503 year: 2003 end-page: 514 article-title: Inhibition of glutamine transport depletes glutamate and GABA neurotransmitter pools: further evidence for metabolic compartmentation publication-title: J. Neurochem. – volume: 63 start-page: 216 year: 2009 end-page: 229 article-title: Calcium dependence of exo‐ and endocytotic coupling at a glutamatergic synapse publication-title: Neuron – volume: 135 start-page: 381 year: 2015 end-page: 394 article-title: Riluzole rescues glutamate alterations, cognitive deficits, and tau pathology associated with P301L tau expression publication-title: J. Neurochem. – volume: 277 start-page: 10467 year: 2002 end-page: 10473 article-title: Localization and functional relevance of system A neutral amino acid transporters in cultured hippocampal neurons publication-title: J. Biol. Chem. – volume: 278 start-page: 23720 year: 2003 end-page: 23730 article-title: Functional properties and cellular distribution of the system A glutamine transporter SNAT1 support specialized roles in central neurons publication-title: J. Biol. Chem. – volume: 284 start-page: 11224 year: 2009 end-page: 11236 article-title: SNAT2 amino acid transporter is regulated by amino acids of the gamma‐aminobutyric acid transporter subfamily in neocortical neurons and may play no role in delivering glutamine for glutamatergic transmission publication-title: J. Biol. Chem. – volume: 23 start-page: 1563 year: 2003 end-page: 1568 article-title: Plasma membrane GABA transporters reside on distinct vesicles and undergo rapid regulated recycling publication-title: J. Neurosci. – volume: 164 start-page: 998 year: 2009 end-page: 1008 article-title: Functional expression of two system A glutamine transporter isoforms in rat auditory brainstem neurons publication-title: Neuroscience – volume: 157 start-page: 349 year: 2002 end-page: 355 article-title: The glutamine commute: take the N line and transfer to the A publication-title: J. Cell Biol. – volume: 12 start-page: 471 year: 1997 end-page: 485 article-title: Glutamate in neurologic diseases publication-title: J. Child Neurol. – volume: 27 start-page: 9192 year: 2007 end-page: 9200 article-title: Excitatory synaptic transmission persists independently of the glutamate‐glutamine cycle publication-title: J. Neurosci. – volume: 3 start-page: 83 year: 1997 end-page: 101 article-title: Neuroprotective profile of riluzole in models of acute neurodegenerative diseases publication-title: CNS Drug Rev. – volume: 8 start-page: 19716 year: 2016 end-page: 19723 article-title: Enhancement in the neuroprotective power of riluzole against cerebral ischemia using a brain targeted drug delivery vehicle publication-title: ACS Appl. Mater. Interfaces. – volume: 286 start-page: 20500 year: 2011 end-page: 20511 article-title: Identification of (SNAT7) protein as a glutamine transporter expressed in neurons publication-title: J. Biol. Chem. – volume: 163 start-page: 755 year: 2007 end-page: 773 article-title: Epileptogenesis in the dentate gyrus: a critical perspective publication-title: Prog. Brain Res. – volume: 419 start-page: 603 year: 1991 end-page: 609 article-title: Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre publication-title: Pflugers Arch. – volume: 27 start-page: 1895 year: 2007 end-page: 1907 article-title: Glutamatergic and GABAergic neurotransmitter cycling and energy metabolism in rat cerebral cortex during postnatal development publication-title: J. Cereb. Blood Flow Metab. – volume: 250 start-page: 473 year: 1993 end-page: 476 article-title: The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1 publication-title: Eur. J. Pharmacol. – volume: 23 start-page: 8212 year: 2003 end-page: 8220 article-title: Brain‐derived neurotrophic factor stimulates energy metabolism in developing cortical neurons publication-title: J. Neurosci. – volume: 33 start-page: 17429 year: 2013 end-page: 17434 article-title: Inducible presynaptic glutamatergic transport supports glutamatergic transmission at the calyx of Held synapse publication-title: J. Neurosci. – volume: 20 start-page: 1342 year: 2000 end-page: 1347 article-title: Neuronal pyruvate carboxylation supports formation of transmitter glutamate publication-title: J. Neurosci. – volume: 16 start-page: 1087 year: 2005 end-page: 1090 article-title: Neuroprotective effect of riluzole in acute noise‐induced hearing loss publication-title: NeuroReport – volume: 48 start-page: 459 year: 2006 end-page: 464 article-title: The glutamine commute: lost in the tube? publication-title: Neurochem. Int. – volume: 76 start-page: 975 year: 2001 end-page: 989 article-title: (13)C NMR measurement of neurotransmitter glutamate cycling, anaplerosis and TCA cycle flux in rat brain during [2‐13C]glucose infusion publication-title: J. Neurochem. – year: 2016 – volume: 147 start-page: 115 year: 1997 end-page: 122 article-title: Differential inhibition by riluzole, lamotrigine, and phenytoin of sodium and calcium currents in cortical neurons: implications for neuroprotective strategies publication-title: Exp. Neurol. – volume: 427 start-page: 1495 year: 2015 end-page: 1512 article-title: Transport of ‐glutamine, ‐alanine, ‐arginine and ‐histidine by the neuron‐specific in CNS publication-title: J. Mol. Biol. – volume: 25 start-page: 6221 year: 2005 end-page: 6234 article-title: Presynaptic regulation of quantal size by the vesicular glutamate transporter VGLUT1 publication-title: J. Neurosci. – volume: 282 start-page: 5152 year: 2007 end-page: 5159 article-title: A critical role for system A amino acid transport in the regulation of dendritic development by brain‐derived neurotrophic factor (BDNF) publication-title: J. Biol. Chem. – volume: 294 start-page: 29 year: 2000 end-page: 32 article-title: Neuroprotective effect of low dose riluzole in gerbil model of transient global ischemia publication-title: Neurosci. Lett. – volume: 45 start-page: 1055 year: 1994 end-page: 1060 article-title: Block of the rat brain IIA sodium channel alpha subunit by the neuroprotective drug riluzole publication-title: Mol. Pharmacol. – volume: 12 start-page: 332 year: 2007 end-page: 343 article-title: Glutamine in the central nervous system: function and dysfunction publication-title: Front Biosci. – volume: 34 start-page: 571 year: 2013 end-page: 585 article-title: Evolutionary origin of amino acid transporter families , and and physiological, pathological and therapeutic aspects publication-title: Mol. Aspects Med. – volume: 269 start-page: 1730 year: 1995 end-page: 1734 article-title: Regulation of hippocampal transmitter release during development and long‐term potentiation publication-title: Science – volume: 76 start-page: 1712 year: 2001 end-page: 1723 article-title: Nitrogen shuttling between neurons and glial cells during glutamate synthesis publication-title: J. Neurochem. – volume: 1371 start-page: 180 year: 2011 end-page: 191 article-title: Chronic electrographic seizure reduces glutamine and elevates glutamate in the extracellular fluid of rat brain publication-title: Brain Res. – volume: 22 start-page: 296 year: 2016 end-page: 305 article-title: Age and Alzheimer's disease gene expression profiles reversed by the glutamate modulator riluzole publication-title: Mol. Psychiatry – volume: 5 start-page: 2145 year: 1980 end-page: 2150 article-title: Comparative study of the release of glutamate and GABA, newly synthesized from glutamine, in various regions of the central nervous system publication-title: Neuroscience – volume: 282 start-page: 707 year: 1997 end-page: 714 article-title: Differential action of riluzole on tetrodotoxin‐sensitive and tetrodotoxin‐resistant sodium channels publication-title: J. Pharmacol. Exp. Ther. – volume: 288 start-page: 1340 year: 1999 end-page: 1348 article-title: Effect of riluzole on the neurological and neuropathological changes in an animal model of cardiac arrest‐induced movement disorder publication-title: J. Pharmacol. Exp. Ther. – volume: 34 start-page: 263 year: 2016 end-page: 272 article-title: Glutamate neurotransmission in rodent models of traumatic brain injury publication-title: J. Neurotrauma – volume: 14 start-page: 7 year: 2013 end-page: 23 article-title: Neurotrophin regulation of neural circuit development and function publication-title: Nat. Rev. Neurosci. – volume: 26 start-page: 671 year: 2000 end-page: 682 article-title: Selective depression of low‐release probablity excitatory synapses by sodium channel blockers publication-title: Neuron – volume: 284 start-page: 8439 year: 2009 end-page: 8448 article-title: Synaptic vesicle protein NTT4/XT1 ( ) catalyzes Na ‐coupled neutral amino acid transport publication-title: J. Biol. Chem. – volume: 277 start-page: 22966 year: 2002 end-page: 22973 article-title: Functional characterization of two novel mammalian electrogenic proton‐dependent amino acid cotransporters publication-title: J. Biol. Chem. – volume: 29 start-page: 317 year: 2013 end-page: 323 article-title: Do sodium channel blockers have neuroprotective effect after onset of ischemic insult? publication-title: Neurol. Res. – volume: 168 start-page: 531 year: 1979 end-page: 541 article-title: Glutamate as a CNS transmitter. II. Regulation of synthesis in the releasable pool publication-title: Brain Res. – volume: 4 start-page: 1 year: 2013 end-page: 16 article-title: The glutamate‐glutamine (GABA) cycle: importance of late postnatal development and potential reciprocal interactions between biosynthesis and degradation publication-title: Front. Endocrinol. – volume: 51 start-page: 39 year: 1997 end-page: 87 article-title: Altered glutamatergic transmission in neurological disorders: from high extracellular glutamate to excessive synaptic efficacy publication-title: Prog. Neurobiol. – volume: 32 start-page: 1239 year: 2010 end-page: 1244 article-title: Acivity‐dependent dendritic secretion of brain‐derived neurotrophic factor modulates synaptic plasticity publication-title: Eur. J. Neurosci. – volume: 70 start-page: 43 year: 1990 end-page: 77 article-title: Role of amino acid transport and countertransport in nutrition and metabolism publication-title: Physiol. Rev. – volume: 140 start-page: 225 year: 1992 end-page: 230 article-title: Neuroprotective actions of riluzole in rodent models of global and focal cerebral ischaemia publication-title: Neurosci. Lett. – volume: 98 start-page: 7206 year: 2001 end-page: 7211 article-title: Identification and characterization of a lysosomal transporter for small neutral amino acids publication-title: Proc. Natl Acad. Sci. – ident: e_1_2_8_9_1 doi: 10.1523/JNEUROSCI.1466-13.2013 – ident: e_1_2_8_36_1 doi: 10.1523/JNEUROSCI.20-04-01342.2000 – ident: e_1_2_8_55_1 doi: 10.1007/s00424-003-1117-9 – ident: e_1_2_8_50_1 doi: 10.1111/j.1460-9568.2010.07378.x – ident: e_1_2_8_58_1 doi: 10.1016/j.ejmech.2016.11.053 – ident: e_1_2_8_14_1 doi: 10.1002/jnr.490350513 – ident: e_1_2_8_89_1 doi: 10.1074/jbc.M806407200 – ident: e_1_2_8_65_1 doi: 10.1038/nrn3379 – ident: e_1_2_8_72_1 doi: 10.1111/j.1460-9568.2007.05967.x – ident: e_1_2_8_32_1 doi: 10.1074/jbc.M806470200 – ident: e_1_2_8_28_1 doi: 10.1016/S0079-6123(07)63041-6 – ident: e_1_2_8_79_1 doi: 10.1006/exnr.1997.6554 – ident: e_1_2_8_2_1 doi: 10.2741/2067 – ident: e_1_2_8_27_1 doi: 10.1089/neu.2015.4373 – ident: e_1_2_8_54_1 doi: 10.1101/lm.54603 – ident: e_1_2_8_13_1 doi: 10.1126/science.7569903 – ident: e_1_2_8_33_1 doi: 10.1074/jbc.M110.162404 – ident: e_1_2_8_81_1 doi: 10.1016/0006-8993(89)90045-0 – ident: e_1_2_8_86_1 doi: 10.1016/j.neuroscience.2004.01.019 – ident: e_1_2_8_17_1 doi: 10.1083/jcb.200201070 – volume-title: Functional identification of an activity‐induced, Ca2+ ‐dependent glutamine transporter in hippocampal neurons year: 2016 ident: e_1_2_8_29_1 contributor: fullname: Erickson J. D. – ident: e_1_2_8_45_1 doi: 10.1016/j.brainres.2010.11.064 – ident: e_1_2_8_51_1 doi: 10.1007/978-3-319-45096-4_8 – ident: e_1_2_8_48_1 doi: 10.1007/s10072-011-0828-5 – ident: e_1_2_8_68_1 doi: 10.1016/0304-3940(92)90108-J – ident: e_1_2_8_40_1 doi: 10.1212/WNL.59.9_suppl_5.S3 – ident: e_1_2_8_67_1 doi: 10.1016/S0896-6273(00)81203-9 – ident: e_1_2_8_59_1 doi: 10.1016/0014-2999(93)90037-I – ident: e_1_2_8_75_1 doi: 10.1016/j.mam.2012.07.012 – ident: e_1_2_8_15_1 doi: 10.1523/JNEUROSCI.23-23-08212.2003 – ident: e_1_2_8_31_1 doi: 10.1111/j.1748-1716.2006.01552.x – ident: e_1_2_8_71_1 doi: 10.1016/0306-4522(80)90130-X – ident: e_1_2_8_8_1 doi: 10.1111/j.1471-4159.1984.tb05396.x – ident: e_1_2_8_35_1 doi: 10.1016/0006-8993(79)90307-X – volume: 282 start-page: 707 year: 1997 ident: e_1_2_8_77_1 article-title: Differential action of riluzole on tetrodotoxin‐sensitive and tetrodotoxin‐resistant sodium channels publication-title: J. Pharmacol. Exp. Ther. contributor: fullname: Song J. H. – ident: e_1_2_8_26_1 doi: 10.1023/A:1015255312948 – ident: e_1_2_8_70_1 doi: 10.1046/j.1471-4159.2003.01713.x – ident: e_1_2_8_84_1 doi: 10.1016/j.neuron.2013.12.026 – ident: e_1_2_8_66_1 doi: 10.1038/mp.2016.33 – ident: e_1_2_8_53_1 doi: 10.1016/S0304-3940(99)00810-1 – ident: e_1_2_8_18_1 doi: 10.1016/0304-3940(92)90597-Z – ident: e_1_2_8_62_1 doi: 10.1042/bj2990321 – ident: e_1_2_8_4_1 doi: 10.1179/016164107X159225 – ident: e_1_2_8_6_1 doi: 10.1016/S0304-3940(00)01536-6 – ident: e_1_2_8_16_1 doi: 10.1074/jbc.M608548200 – ident: e_1_2_8_44_1 doi: 10.1523/JNEUROSCI.1198-07.2007 – ident: e_1_2_8_80_1 doi: 10.1111/j.1527-3458.1997.tb00318.x – ident: e_1_2_8_10_1 doi: 10.1177/088307389701200802 – ident: e_1_2_8_20_1 doi: 10.1152/physrev.1990.70.1.43 – ident: e_1_2_8_25_1 doi: 10.1212/WNL.47.6_Suppl_4.233S – ident: e_1_2_8_46_1 doi: 10.1016/j.eplepsyres.2013.08.007 – ident: e_1_2_8_11_1 doi: 10.1016/j.neuroscience.2009.09.015 – ident: e_1_2_8_73_1 doi: 10.1097/00001756-200507130-00011 – volume: 25 start-page: 7121 year: 2005 ident: e_1_2_8_23_1 article-title: Homeostatic scaling of vesicular glutamate and GABA transporter expression in rat neocortical circuits publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.5221-04.2005 contributor: fullname: Gois S. – ident: e_1_2_8_7_1 doi: 10.1007/BF00370302 – ident: e_1_2_8_21_1 doi: 10.1007/s13311-014-0305-y – ident: e_1_2_8_19_1 doi: 10.1038/sj.jcbfm.9600490 – ident: e_1_2_8_76_1 doi: 10.1046/j.1471-4159.2001.00074.x – ident: e_1_2_8_88_1 doi: 10.1523/JNEUROSCI.3003-04.2005 – ident: e_1_2_8_57_1 doi: 10.1523/JNEUROSCI.09-11-03720.1989 – ident: e_1_2_8_43_1 doi: 10.1093/cercor/bhn151 – ident: e_1_2_8_30_1 doi: 10.1523/JNEUROSCI.23-30-09697.2003 – volume: 45 start-page: 1055 year: 1994 ident: e_1_2_8_37_1 article-title: Block of the rat brain IIA sodium channel alpha subunit by the neuroprotective drug riluzole publication-title: Mol. Pharmacol. contributor: fullname: Herbert T. – ident: e_1_2_8_74_1 doi: 10.1073/pnas.121183498 – ident: e_1_2_8_61_1 doi: 10.1046/j.1460-9568.1999.00540.x – ident: e_1_2_8_52_1 doi: 10.1046/j.1471-4159.2001.00156.x – ident: e_1_2_8_63_1 doi: 10.1016/j.biopha.2016.12.067 – ident: e_1_2_8_34_1 doi: 10.1016/j.jmb.2014.10.016 – ident: e_1_2_8_78_1 doi: 10.1097/00001756-200207020-00019 – ident: e_1_2_8_85_1 doi: 10.1021/acsami.6b01776 – ident: e_1_2_8_49_1 doi: 10.1007/PL00005241 – ident: e_1_2_8_56_1 doi: 10.1074/jbc.M212718200 – volume: 288 start-page: 1340 year: 1999 ident: e_1_2_8_47_1 article-title: Effect of riluzole on the neurological and neuropathological changes in an animal model of cardiac arrest‐induced movement disorder publication-title: J. Pharmacol. Exp. Ther. contributor: fullname: Kanthasamy A. G. – ident: e_1_2_8_60_1 doi: 10.1002/jnr.23561 – ident: e_1_2_8_12_1 doi: 10.1074/jbc.M200374200 – ident: e_1_2_8_39_1 doi: 10.1016/j.neuroscience.2005.08.083 – ident: e_1_2_8_41_1 doi: 10.1016/j.neuron.2009.06.010 – ident: e_1_2_8_64_1 doi: 10.1016/S0301-0082(96)00049-4 – ident: e_1_2_8_69_1 doi: 10.1097/00001756-199806220-00037 – ident: e_1_2_8_22_1 doi: 10.1016/j.neuint.2005.11.016 – ident: e_1_2_8_87_1 doi: 10.1152/jn.00464.2004 – ident: e_1_2_8_42_1 doi: 10.1111/jnc.13230 – ident: e_1_2_8_82_1 doi: 10.1111/j.1471-4159.2012.07684.x – ident: e_1_2_8_3_1 doi: 10.1074/jbc.M110942200 – ident: e_1_2_8_38_1 doi: 10.3389/fendo.2013.00059 – ident: e_1_2_8_83_1 doi: 10.1523/JNEUROSCI.0106-09.2010 – ident: e_1_2_8_5_1 doi: 10.1152/jn.00665.2001 – volume: 23 start-page: 1563 year: 2003 ident: e_1_2_8_24_1 article-title: Plasma membrane GABA transporters reside on distinct vesicles and undergo rapid regulated recycling publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.23-05-01563.2003 contributor: fullname: Deken S. L. |
SSID | ssj0016461 |
Score | 2.3844976 |
Snippet | Glutamine (Gln) is considered the preferred precursor for the neurotransmitter pool of glutamate (Glu), the major excitatory transmitter in the mammalian CNS.... Abstract Glutamine (Gln) is considered the preferred precursor for the neurotransmitter pool of glutamate (Glu), the major excitatory transmitter in the... |
SourceID | pubmedcentral proquest crossref pubmed wiley |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 29 |
SubjectTerms | activity‐dependent regulation Affinity Amino Acid Transport System X-AG - drug effects Amino acids Animals Astrocytes Astrocytes - drug effects Astrocytes - metabolism Axonal transport beta-Alanine - analogs & derivatives beta-Alanine - metabolism Calcium Calcium (extracellular) Calcium - metabolism Calcium Channel Blockers - pharmacology Calcium channels Calcium channels (voltage-gated) Calcium transport Central nervous system Channels Circuits Competition Displays Enrichment Excitatory Amino Acid Antagonists - pharmacology Excitotoxicity Female Functional anatomy glutamate/glutamine cycle Glutamatergic transmission Glutamic acid Glutamine Glutamine - metabolism Hippocampus Hippocampus - cytology Hippocampus - drug effects Hippocampus - metabolism In vitro methods and tests Inhibition Inhibitors Ions Low concentrations Mammals Maturation Nervous system Neural networks neuronal glutamine transporter Neurons Neurons - drug effects Neurons - metabolism neuroprotection Neuroprotective Agents - pharmacology Neurosciences neurotransmitter cycling Physiology Potassium - pharmacology Pregnancy Rats Rats, Sprague-Dawley Riluzole - pharmacology Sodium channels (voltage-gated) Tetrodotoxin Transport γ-Aminobutyric acid |
Title | Functional identification of activity‐regulated, high‐affinity glutamine transport in hippocampal neurons inhibited by riluzole |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjnc.14046 https://www.ncbi.nlm.nih.gov/pubmed/28423185 https://www.proquest.com/docview/1911516892 https://search.proquest.com/docview/1891089828 https://pubmed.ncbi.nlm.nih.gov/PMC5594568 |
Volume | 142 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB5CLu2lTZM-3KRBLaX0UIesLckyPYWlSwg0h9JADgUjyVJjuvEu-zhsToH8gf7G_pLOyA-yCYHSm7HHtizN4xt59AngvXSpV5L7WGtlY26zNM5zk8VCZ7nR7lCVhqYGvp7K4zN-ci7ON-Bztxam4YfoJ9zIMoK_JgPXZn7byNF-iBuG6LaJSI8A0beeOoposwY9UzhqZssqFKp4ujvXY9E9gHm_TvI2fg0BaPQUfnRNb-pOfh0sF-bAXt1hdfzPb9uCJy0wZUeNJj2DDVdvw85RjUn55Yp9YKFUNMzBb8OjYbdN3A7cjDAyNhOKrCrb2qMw3GziGS2boN0p_lz_njW73rvyEyOOZDyjva_Qo6zYT1R_fYmtZouOa51VNYpNpxhq0WGNWeDdrOd4-qIyBJOZWbFZNV5eTcbuOZyNvnwfHsftzg6x5TyVsRfGEhWhcCk6XO5L9CK5Mtoantgk0S5LtOBaKIcSEjMiaZVxQshSe-2dTl_AZj2p3StgYqAPrbA5qpzhIucmKzOBGjgYSF-mUkTwrhvjYtoQeBR94lPbInRzBHvd6BetDc8LzGQRDkmVJxG87S9j79IvFV27yRJlFMItlWPaGsHLRln6t2DgT2htegTZmhr1AsTsvX6lri4CwzemeQhs8Zkfg5Y83PDi5HQYDl7_u-guPE4Im4Sa4z3YXMyW7g0iq4XZDya0T9FN_AUf5icS |
link.rule.ids | 230,315,786,790,891,1382,27955,27956,46327,46751 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VcigXHi2PlAIGIcSBVN3EdhyJS7WwWkq7B9RKvaDIdmwadetdbXcP2xMSf4DfyC9h7DzUpUJC3KJkknjjeXwzO_4M8Jqb1ApObSyl0DHVWRrnucpiJrNcSbMnSuVLA0cjPjyhB6fsdA3et2than6IruDmLSP4a2_gviB93crRgDw5DL8Ft9HcmTfLD1868ihPnNXruMJRNxteodDH0966Go1uQMybnZLXEWwIQYN78LUdfN15cr67mKtdffUHr-P__rr7cLfBpmS_VqYHsGbcJmztO8zLL5bkDQndoqEMvwkb_XanuC34McDgWNcUSVU27UdhxsnEEr9ywm9Q8ev7z1m98b0p3xFPk4xnpLUVOpUl-YYWIC9w2GTe0q2TyqHYdIrRFn3WmATqTXeJp88q5ZEyUUsyq8aLq8nYPISTwcfj_jBuNneINaUpjy1T2rMRMpOiz6W2REeSCyW1oolOEmmyRDIqmTAowTEp4loowxgvpZXWyPQRrLuJM0-AsJ7c00znqHWKspyqrMwYKmGvx22ZchbBq3aSi2nN4VF0uY_TRfjMEey00180ZnxZYDKLiIiLPIngZXcZv67_V0U6M1mgjEDEJXLMXCN4XGtL9xaM_Ylfnh5BtqJHnYAn91694qqzQPKNmR5iW3zm26Amfx94cTDqh4Ptfxd9ARvD46PD4vDT6PNTuJN4qBJakHdgfT5bmGcItObqebCn33TYKkw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIgEXHi2PQAGDEOLQVN3Edhz1VG1ZlQIrhKjUA1JkOzaN2HpX293D9oTEH-hv7C_p2HmoS4WEuEXJJHHseXzjjD8DvOEmtYJTG0spdEx1lsZ5rrKYySxX0myLUvmpgc9Dvn9ID47Y0QrstGthan6IbsLNW0bw197AJ6W9auRoP54bht-Am5Snic-89r523FGeN6vXUYWjaja0QqGMp711ORhdQ5jXCyWvAtgQgQb34Hvb9rrw5OfWfKa29NkftI7_-XH34W6DTMlurUoPYMW4NVjfdZiVnyzIWxJqRcMk_Brc7rf7xK3D7wGGxnpGkVRlU3wUxpuMLfHrJvz2FBe_zqf1tvem3CSeJBnPSGsrdCkL8gP1X55gq8msJVsnlUOxyQRjLXqsEQnEm-4UTx9XyuNkohZkWo3mZ-OReQiHg_ff-vtxs7VDrClNeWyZ0p6LkJkUPS61JbqRXCipFU10kkiTJZJRyYRBCY4pEddCGcZ4Ka20RqaPYNWNnXkChPXktmY6R51TlOVUZWXGUAV7PW7LlLMIXrdjXExqBo-iy3ycLkI3R7DRjn7RGPFpgaks4iEu8iSCV91l7F3_T0U6M56jjEC8JXLMWyN4XCtL9xaM_IlfnB5BtqRGnYCn9l6-4qrjQPGNeR4iW3zmu6Alf294cTDsh4On_y76Em592RsUnz4MPz6DO4nHKaH-eANWZ9O5eY4oa6ZeBGu6BO1UKPs |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Functional+identification+of+activity%E2%80%90regulated%2C+high%E2%80%90affinity+glutamine+transport+in+hippocampal+neurons+inhibited+by+riluzole&rft.jtitle=Journal+of+neurochemistry&rft.au=Erickson%2C+Jeffrey+D.&rft.date=2017-07-01&rft.issn=0022-3042&rft.eissn=1471-4159&rft.volume=142&rft.issue=1&rft.spage=29&rft.epage=40&rft_id=info:doi/10.1111%2Fjnc.14046&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_jnc_14046 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3042&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3042&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3042&client=summon |